Gilead Prices COVID-19 Drug Candidate Remdesivir at ...
Gilead Sciences Inc has priced its COVID-19 drug candidate remdesivir at $390 per vial for the United States and governments of other developed countries, it said on Monday, setting the price of a five-day cou...
June 29, 2020
12:33 pm By Neha Mule